Skip to content

Clinical trials

Completed Alzheimer Disease trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Finland Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20062
20071
20081
20094
20102
20112
20121
20133
20144
20152
20161
20171
20181
20192
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Eastern Finland3
Eli Lilly and Company2
H. Lundbeck A/S2
Hoffmann-La Roche2
Orion Corporation, Orion Pharma2
AC Immune SA1
AbbVie1
Alzinova AB1
Bayer1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease33
Dementia10
Cognitive Dysfunction6
Memory Disorders3
Neurodegenerative Diseases3
Brain Diseases2
Lymphoma, Follicular2
Nervous System Diseases2
Tauopathies2
Central Nervous System Diseases1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.